Production (Stage)
Cognition Therapeutics, Inc.
CGTX
$0.3132
$0.01495.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.48M | -7.84M | -9.94M | -7.04M | -9.15M |
| Total Depreciation and Amortization | 45.00K | 71.00K | 70.00K | 67.00K | 58.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 586.00K | 534.00K | 896.00K | 1.15M | 1.37M |
| Change in Net Operating Assets | -2.03M | -1.15M | 2.12M | -170.00K | 483.00K |
| Cash from Operations | -9.88M | -8.38M | -6.85M | -6.00M | -7.24M |
| Capital Expenditure | -- | -1.00K | 0.00 | -3.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -1.00K | 0.00 | -3.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -118.00K | -195.00K | -185.00K | -181.00K | -178.00K |
| Issuance of Common Stock | 1.46M | 12.91M | 514.00K | 65.00K | 12.28M |
| Repurchase of Common Stock | -46.00K | 0.00 | 0.00 | -22.00K | -106.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.33M | -- | -- | -- |
| Cash from Financing | 1.30M | 11.38M | 329.00K | -138.00K | 11.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.58M | 3.00M | -6.52M | -6.14M | 4.75M |